查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434562

適體市場：按產品、應用和最終用戶分類 - 2024-2030 年全球預測

Aptamers Market by Product (Nucleotide Based, Peptide Based), Application (Diagnostics, Research & Development, Therapeutics Development), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年適配體市場規模為13.4億美元，預計2024年將達到14.8億美元，2030年將達到27.7億美元，複合年成長率為10.91%。

全球適體市場

主要市場統計
基準年[2023] 13.4億美元
預測年份 [2024] 14.8億美元
預測年份 [2030] 27.7億美元
複合年成長率（%） 10.91%
適體市場-IMG1

適體是含有 DNA、RNA 或修飾核酸的單鏈寡核苷酸，能夠與目標分子特異性結合並具有高親和性。這些目標分子可以是蛋白質、胜肽、小有機化合物、核酸或整個細胞。適體的重要性在於其獨特的性質在生物技術中的廣泛應用。適配體對抗體等標靶具有較高的特異性和親和性，具有體積小、易於化學合成、可修飾穩定性等優點，可用於靶向藥物遞送系統，是一種很好的診斷工具。此外，適體由天然存在的核苷酸組成，因此與抗體相比具有最小的免疫抗原性。適體可以設計用於多重檢測或與其他生物功能部分（例如奈米顆粒或螢光染料）結合，增加其在各個領域的適用性。由於多種因素，適體市場正在經歷顯著成長，包括藥物開發投資、政府促進個人化醫療的舉措以及基於適體的生物感測器和照護現場診斷的不斷發展。然而，開發複雜性和監管限制等挑戰給適體市場帶來了障礙。市場相關人員正在研究新的製造技術，以簡化適配體的製造流程並提高其品質。合成化學和高通量篩檢技術的進步使得修飾核酸文庫的開發能夠產生更穩定且功能性更強的適體。

區域洞察

美洲地區代表了全球適體市場的重大發展，擁有完善的生物技術領域，並透過強大的學術基礎和對研發活動的大量投資而加強。在美洲地區的應用領域，適配體廣泛應用於針對癌症治療、發炎疾病治療、診斷和管理的藥物發現活動。適體在環境監測和食品安全應用方面取得了重大進展。在德國、法國和英國等先進的生物製藥領域，適配體廣泛用於治療應用和診斷工具的開發。歐洲研究人員在利用適配體檢測植物病原體和監測食品污染的農業應用方面取得了重大進展。在亞洲，由於生物製藥投資和政府資助的增加，適配體正處於早期階段，具有快速成長的潛力。中國、印度、韓國和日本等新興市場正在主導該地區的研究工作。儘管與美洲和歐洲相比，亞洲的專業適配體公司數量有限，但這些國家有幾家大型製藥公司將適配體研究作為其藥物發現管道的一部分來進行。亞洲研究人員對使用適配體作為診斷工具和治療方法來治療心血管和神經退化性疾病等慢性疾病越來越感興趣。

FPNV定位矩陣

FPNV定位矩陣對於評估適配體市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對適配體市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-適配體市場規模和預測是多少？

2-適配體市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-適配體市場的技術趨勢和法律規範是什麼？

4-適配體市場主要廠商的市場佔有率為何？

5-進入適配體市場的合適型態或策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 投資藥物開發並使用適體進行藥物結合親和性
      • 政府鼓勵個人化醫療和治療的舉措
      • 基於適體的生物感測器和照護現場診斷的不斷發展
    • 抑制因素
      • 對適體半衰期短的擔憂
    • 機會
      • 適體生產與功能的技術進步
      • 適體在食品安全與真偽檢測的應用的出現
    • 任務
      • 開發複雜性和監管限制
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章適體市場：依產品

  • 核苷酸鹼基
    • DNA
    • RNA
    • XNA
  • 基於胜肽的

第7章適體市場：依應用分類

  • 診斷
  • 研究與開發
  • 治療藥物的開發

第 8 章適體市場：依最終使用者分類

  • 學術和政府研究機構
  • 生物技術和製藥公司
  • 合約研究組織

第9章 美洲適體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區適配體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲適配體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強
    • 獎項/獎勵/擴展

第13章競爭產品組合

  • 主要公司簡介
    • 2bind GmbH
    • Agilent Technologies, Inc.
    • Aptagen, LLC
    • Aptamer Group
    • Aptamer Sciences, Inc.
    • AptaTargets SL
    • Aptus Biotech SL
    • ATDBio Ltd.
    • Base Pair Biotechnologies, Inc.
    • Basking Biosciences
    • Cage Bio, Inc.
    • Creative Biogene
    • Drive Therapeutics, LLC
    • IVERIC bio, Inc.
    • Kaneka Corporation
    • Maravai LifeSciences
    • Mediomics, LLC
    • NeoVentures Biotechnology, Inc.
    • NOVAPTECH
    • Novartis AG
    • Qualigen, Inc.
    • Raptamer Discovery Group
    • SomaLogic, Inc.
    • TAGCyx Biotechnologies Inc.
    • Vivonics, Inc.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-4358BACA83A7

[183 Pages Report] The Aptamers Market size was estimated at USD 1.34 billion in 2023 and expected to reach USD 1.48 billion in 2024, at a CAGR 10.91% to reach USD 2.77 billion by 2030.

Global Aptamers Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.34 billion
Estimated Year [2024] USD 1.48 billion
Forecast Year [2030] USD 2.77 billion
CAGR (%) 10.91%
Aptamers Market - IMG1

Aptamers are single-stranded oligonucleotides, including DNA, RNA, or modified nucleic acids, that have the ability to bind specifically and with high affinity to their target molecules. These target molecules can be proteins, peptides, small organic compounds, nucleic acids, or whole cells. The importance of aptamers lies in their numerous applications in biotechnology due to their unique characteristics. They exhibit high specificity and affinity for their targets akin to antibodies and possess advantages such as smaller size, ease of chemical synthesis, and modification for stability, making them suitable candidates for targeted drug delivery systems or diagnostic tools. Moreover, aptamers have minimal immunogenicity compared to antibodies since they comprise natural nucleotides. Aptamers can be engineered for multiplex detection or combined with other biofunctional moieties, such as nanoparticles or fluorophores, to enhance their applicability across various sectors. The aptamers market is experiencing significant growth driven by various factors, such as investments in drug development, government initiatives promoting personalized medicine, and the rising development of aptamer-based biosensors and point-of-care diagnostics. However, challenges such as development complexity and regulatory limitations pose hurdles for the aptamers market. Market players are working on new production technologies to ease the aptamer manufacturing process and improve their quality. Advances in synthetic chemistry and high-throughput screening technologies have enabled the development of modified nucleic acid libraries to generate more stable and functional aptamers.

Regional Insights

The Americas region exhibits significant advancements in the global aptamer market, with an established biotechnology sector bolstered by a strong academic foundation and substantial investment in R&D activities. In terms of application areas within the Americas region, aptamers are widely used in drug discovery efforts targeting cancer therapy, treatment of inflammatory diseases, diagnosis & management. Significant advancements have been made in employing aptamers for environmental monitoring and food safety applications. Europe represents an evolving landscape for aptamers as countries such as Germany, France, and the UK have advanced biopharmaceutical sectors that use this technology extensively for therapeutic applications or diagnostics tool development. European researchers have made significant strides in using aptamers for agricultural applications, wherein they are employed to detect plant pathogens or monitor food contamination. In Asia, the aptamer landscape is at a nascent stage with potential for rapid growth due to increasing biopharmaceutical investments and government funding initiatives. Emerging markets, including China, India, South Korea, and Japan, are leading regional research activities. Although there is a limited number of dedicated aptamer-based companies in Asia compared to the Americas and Europe, these countries harbor several large-scale pharmaceutical entities that engage in aptamer research as part of their drug discovery pipelines. Asian researchers have demonstrated a growing interest in utilizing aptamers as diagnostic tools or therapeutic agents for chronic disease management, such as cardiovascular ailments or neurodegenerative conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Aptamers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aptamers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Aptamers Market, highlighting leading vendors and their innovative profiles. These include 2bind GmbH, Agilent Technologies, Inc., Aptagen, LLC, Aptamer Group, Aptamer Sciences, Inc., AptaTargets SL, Aptus Biotech S.L., ATDBio Ltd., Base Pair Biotechnologies, Inc., Basking Biosciences, Cage Bio, Inc., Creative Biogene, Drive Therapeutics, LLC, IVERIC bio, Inc., Kaneka Corporation, Maravai LifeSciences, Mediomics, LLC, NeoVentures Biotechnology, Inc., NOVAPTECH, Novartis AG, Qualigen, Inc., Raptamer Discovery Group, SomaLogic, Inc., TAGCyx Biotechnologies Inc., and Vivonics, Inc..

Market Segmentation & Coverage

This research report categorizes the Aptamers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Nucleotide Based
      • DNA
      • RNA
      • XNA
    • Peptide Based
  • Application
    • Diagnostics
    • Research & Development
    • Therapeutics Development
  • End-User
    • Academic & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Aptamers Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aptamers Market?

3. What are the technology trends and regulatory frameworks in the Aptamers Market?

4. What is the market share of the leading vendors in the Aptamers Market?

5. Which modes and strategic moves are suitable for entering the Aptamers Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Aptamers Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Investments in drug development and use of aptamers for drug-binding affinity
      • 5.1.1.2. Government initiatives encouraging personalized medicine and treatment
      • 5.1.1.3. Rising development of aptamer-based biosensors and point-of-care diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with short half-life of aptamers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in aptamer production and functionalities
      • 5.1.3.2. Emergence use of aptamers for food safety and authenticity testing
    • 5.1.4. Challenges
      • 5.1.4.1. Development complexity and regulatory limitations
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Aptamers Market, by Product

  • 6.1. Introduction
  • 6.2. Nucleotide Based
    • 6.3.1. DNA
    • 6.3.2. RNA
    • 6.3.3. XNA
  • 6.3. Peptide Based

7. Aptamers Market, by Application

  • 7.1. Introduction
  • 7.2. Diagnostics
  • 7.3. Research & Development
  • 7.4. Therapeutics Development

8. Aptamers Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Aptamers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Aptamers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Aptamers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Agreement, Collaboration, & Partnership
      • 12.3.1.1. Zentek and McMaster Announce Positive Results for the Aptamer Platform
      • 12.3.1.2. Aptamer Group and Neuro-Bio Collaborate to Develop Alzheimer's Disease Diagnostic Test
    • 12.3.2. New Product Launch & Enhancement
      • 12.3.2.1. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
    • 12.3.3. Award, Recognition, & Expansion
      • 12.3.3.1. Aptamer Opens New Facilities to Meet Growing Demand for Optimer Technology

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. 2bind GmbH
    • 13.1.2. Agilent Technologies, Inc.
    • 13.1.3. Aptagen, LLC
    • 13.1.4. Aptamer Group
    • 13.1.5. Aptamer Sciences, Inc.
    • 13.1.6. AptaTargets SL
    • 13.1.7. Aptus Biotech S.L.
    • 13.1.8. ATDBio Ltd.
    • 13.1.9. Base Pair Biotechnologies, Inc.
    • 13.1.10. Basking Biosciences
    • 13.1.11. Cage Bio, Inc.
    • 13.1.12. Creative Biogene
    • 13.1.13. Drive Therapeutics, LLC
    • 13.1.14. IVERIC bio, Inc.
    • 13.1.15. Kaneka Corporation
    • 13.1.16. Maravai LifeSciences
    • 13.1.17. Mediomics, LLC
    • 13.1.18. NeoVentures Biotechnology, Inc.
    • 13.1.19. NOVAPTECH
    • 13.1.20. Novartis AG
    • 13.1.21. Qualigen, Inc.
    • 13.1.22. Raptamer Discovery Group
    • 13.1.23. SomaLogic, Inc.
    • 13.1.24. TAGCyx Biotechnologies Inc.
    • 13.1.25. Vivonics, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. APTAMERS MARKET RESEARCH PROCESS
  • FIGURE 2. APTAMERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. APTAMERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. APTAMERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. APTAMERS MARKET DYNAMICS
  • FIGURE 7. APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. APTAMERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. APTAMERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. APTAMERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. APTAMERS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. APTAMERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. APTAMERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL APTAMERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 8. APTAMERS MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. APTAMERS MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. APTAMERS MARKET SIZE, BY XNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. APTAMERS MARKET SIZE, BY PEPTIDE BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. APTAMERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. APTAMERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. APTAMERS MARKET SIZE, BY THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. APTAMERS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. APTAMERS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. APTAMERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES APTAMERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA APTAMERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM APTAMERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM APTAMERS MARKET SIZE, BY NUCLEOTIDE BASED, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM APTAMERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM APTAMERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. APTAMERS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. APTAMERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. APTAMERS MARKET LICENSE & PRICING